Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Ulcerative Colitis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global ulcerative colitis market reached a value of US$ 6.92 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 9.71 Billion by 2027, exhibiting a CAGR of 5.60% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Ulcerative colitis (UC) refers to a chronic inflammatory bowel disease (IBD) that causes irritation, inflammation, and ulcers (sores) in the digestive tract. It typically affects the inner lining of the large intestine (or colon) and rectum. The symptoms generally develop over time, and individuals diagnosed with UC may experience periods of mild or no symptoms. However, it can sometimes lead to debilitating or life-threatening complications. While there is no cure for UC yet, the treatment can help patients manage and reduce their symptoms, prevent flare-ups, and bring about long-term remission. As a result, UC treatment is rapidly gaining traction across the globe as it can help enhance the quality of life and ensure the physical and mental wellbeing of the patients.  

Ulcerative Colitis Market Trends:

The widespread prevalence of UC disease and the rising awareness regarding the available treatment options represent the primary factors driving the market growth. Besides this, the presence of strong pipeline products and continuous advancements in numerous drugs are augmenting the product demand. Additionally, governments of various countries are taking several initiatives to spread awareness about the condition and enhance the accessibility and availability of proper healthcare facilities. This, in confluence with the increasing investments in the research and development (R&D) activities for the development of novel therapies, is propelling the market growth. Furthermore, the leading players are focusing on launching innovative and more effective drugs to expand their product portfolio and gain a competitive edge in the market. Other factors, including the easy availability of biosimilar drugs, improving healthcare infrastructure, favorable reimbursement policies, and increasing consumer spending on healthcare, are also creating a positive market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global ulcerative colitis market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, disease type, molecule type, drug type, route of administration and distribution channel.

Breakup by Type:

  • Mild UC
  • Moderate UC
  • Severe UC
     

Breakup by Disease Type:

  • Ulcerative Proctitis
  • Proctosigmoiditis
  • Left-sided Colitis
  • Pancolitis or Universal Colitis
  • Fulminant Colitis
     

Breakup by Molecule Type:

  • Small Molecules
  • Biologics
     

Breakup by Drug Type:

  • Anti-Inflammatory Drugs
  • Anti-TNF Biologics
  • Immunosuppressant
  • Calcineurin Inhibitors
  • Others
     

Breakup by Route of Administration:

  • Oral
  • Injectable
     

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Store
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AbbVie Inc., AstraZeneca plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Type, Disease Type, Molecule Type, Drug Type, Route of Administration, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, AbbVie Inc., AstraZeneca plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global ulcerative colitis market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global ulcerative colitis market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the disease type?
  • What is the breakup of the market based on the molecule type?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global ulcerative colitis market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Ulcerative Colitis Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Type
    6.1    Mild UC
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Moderate UC
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Severe UC
        6.3.1 Market Trends
        6.3.2 Market Forecast
7    Market Breakup by Disease Type
    7.1    Ulcerative Proctitis
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Proctosigmoiditis
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Left-sided Colitis
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Pancolitis or Universal Colitis
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Fulminant Colitis
        7.5.1 Market Trends
        7.5.2 Market Forecast
8    Market Breakup by Molecule Type
    8.1    Small Molecules
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Biologics
        8.2.1 Market Trends
        8.2.2 Market Forecast
9    Market Breakup by Drug Type
    9.1    Anti-Inflammatory Drugs
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Anti-TNF Biologics
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Immunosuppressant
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Calcineurin Inhibitors
        9.4.1 Market Trends
        9.4.2 Market Forecast
    9.5    Others
        9.5.1 Market Trends
        9.5.2 Market Forecast
10    Market Breakup by Route of Administration
    10.1    Oral
        10.1.1 Market Trends
        10.1.2 Market Forecast
    10.2    Injectable
        10.2.1 Market Trends
        10.2.2 Market Forecast
11    Market Breakup by Distribution Channel
    11.1    Hospital Pharmacies
        11.1.1 Market Trends
        11.1.2 Market Forecast
    11.2    Retail Pharmacies
        11.2.1 Market Trends
        11.2.2 Market Forecast
    11.3    Drug Store
        11.3.1 Market Trends
        11.3.2 Market Forecast
    11.4    Others
        11.4.1 Market Trends
        11.4.2 Market Forecast
12    Market Breakup by Region
    12.1    North America
        12.1.1 United States
           12.1.1.1 Market Trends
           12.1.1.2 Market Forecast
        12.1.2 Canada
           12.1.2.1 Market Trends
           12.1.2.2 Market Forecast
    12.2    Asia-Pacific
        12.2.1 China
           12.2.1.1 Market Trends
           12.2.1.2 Market Forecast
        12.2.2 Japan
           12.2.2.1 Market Trends
           12.2.2.2 Market Forecast
        12.2.3 India
           12.2.3.1 Market Trends
           12.2.3.2 Market Forecast
        12.2.4 South Korea
           12.2.4.1 Market Trends
           12.2.4.2 Market Forecast
        12.2.5 Australia
           12.2.5.1 Market Trends
           12.2.5.2 Market Forecast
        12.2.6 Indonesia
           12.2.6.1 Market Trends
           12.2.6.2 Market Forecast
        12.2.7 Others
           12.2.7.1 Market Trends
           12.2.7.2 Market Forecast
    12.3    Europe
        12.3.1 Germany
           12.3.1.1 Market Trends
           12.3.1.2 Market Forecast
        12.3.2 France
           12.3.2.1 Market Trends
           12.3.2.2 Market Forecast
        12.3.3 United Kingdom
           12.3.3.1 Market Trends
           12.3.3.2 Market Forecast
        12.3.4 Italy
           12.3.4.1 Market Trends
           12.3.4.2 Market Forecast
        12.3.5 Spain
           12.3.5.1 Market Trends
           12.3.5.2 Market Forecast
        12.3.6 Russia
           12.3.6.1 Market Trends
           12.3.6.2 Market Forecast
        12.3.7 Others
           12.3.7.1 Market Trends
           12.3.7.2 Market Forecast
    12.4    Latin America
        12.4.1 Brazil
           12.4.1.1 Market Trends
           12.4.1.2 Market Forecast
        12.4.2 Mexico
           12.4.2.1 Market Trends
           12.4.2.2 Market Forecast
        12.4.3 Others
           12.4.3.1 Market Trends
           12.4.3.2 Market Forecast
    12.5    Middle East and Africa
        12.5.1 Market Trends
        12.5.2 Market Breakup by Country
        12.5.3 Market Forecast
13    SWOT Analysis
    13.1    Overview
    13.2    Strengths
    13.3    Weaknesses
    13.4    Opportunities
    13.5    Threats
14    Value Chain Analysis
15    Porters Five Forces Analysis

    15.1    Overview
    15.2    Bargaining Power of Buyers
    15.3    Bargaining Power of Suppliers
    15.4    Degree of Competition
    15.5    Threat of New Entrants
    15.6    Threat of Substitutes
16    Price Analysis
17    Competitive Landscape

    17.1    Market Structure
    17.2    Key Players
    17.3    Profiles of Key Players
        17.3.1    Abbott Laboratories
           17.3.1.1 Company Overview
           17.3.1.2 Product Portfolio
           17.3.1.3 Financials
           17.3.1.4 SWOT Analysis
        17.3.2    AbbVie Inc.
           17.3.2.1 Company Overview
           17.3.2.2 Product Portfolio
           17.3.2.3 Financials
           17.3.2.4 SWOT Analysis
        17.3.3    AstraZeneca plc
           17.3.3.1 Company Overview
           17.3.3.2 Product Portfolio
           17.3.3.3 Financials
           17.3.3.4 SWOT Analysis
        17.3.4    Bristol-Myers Squibb Company
           17.3.4.1 Company Overview
           17.3.4.2 Product Portfolio
           17.3.4.3 Financials
           17.3.4.4 SWOT Analysis
        17.3.5    Eli Lilly and Company
           17.3.5.1 Company Overview
           17.3.5.2 Product Portfolio
           17.3.5.3 Financials
           17.3.5.4 SWOT Analysis
        17.3.6    F. Hoffmann-La Roche Ltd.
           17.3.6.1 Company Overview
           17.3.6.2 Product Portfolio
           17.3.6.3 Financials
        17.3.7    GlaxoSmithKline plc
           17.3.7.1 Company Overview
           17.3.7.2 Product Portfolio
           17.3.7.3 Financials
           17.3.7.4 SWOT Analysis
        17.3.8    Johnson & Johnson
           17.3.8.1 Company Overview
           17.3.8.2 Product Portfolio
           17.3.8.3 Financials
           17.3.8.4 SWOT Analysis
        17.3.9    Merck & Co. Inc.
           17.3.9.1 Company Overview
           17.3.9.2 Product Portfolio
           17.3.9.3 Financials
           17.3.9.4 SWOT Analysis
        17.3.10    Pfizer Inc.
           17.3.10.1 Company Overview
           17.3.10.2 Product Portfolio
           17.3.10.3 Financials
           17.3.10.4 SWOT Analysis
        17.3.11    Takeda Pharmaceutical Company Limited
           17.3.11.1 Company Overview
           17.3.11.2 Product Portfolio
           17.3.11.3 Financials
           17.3.11.4 SWOT Analysis
        17.3.12    Teva Pharmaceutical Industries Ltd.
           17.3.12.1 Company Overview
           17.3.12.2 Product Portfolio
           17.3.12.3 Financials
           17.3.12.4 SWOT Analysis

List of Figures

Figure 1: Global: Ulcerative Colitis Market: Major Drivers and Challenges
Figure 2: Global: Ulcerative Colitis Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Ulcerative Colitis Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Ulcerative Colitis Market: Breakup by Type (in %), 2021
Figure 5: Global: Ulcerative Colitis Market: Breakup by Disease Type (in %), 2021
Figure 6: Global: Ulcerative Colitis Market: Breakup by Molecule Type (in %), 2021
Figure 7: Global: Ulcerative Colitis Market: Breakup by Drug Type (in %), 2021
Figure 8: Global: Ulcerative Colitis Market: Breakup by Route of Administration (in %), 2021
Figure 9: Global: Ulcerative Colitis Market: Breakup by Distribution Channel (in %), 2021
Figure 10: Global: Ulcerative Colitis Market: Breakup by Region (in %), 2021
Figure 11: Global: Ulcerative Colitis (Mild UC) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Ulcerative Colitis (Mild UC) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Ulcerative Colitis (Moderate UC) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Ulcerative Colitis (Moderate UC) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Ulcerative Colitis (Severe UC) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Ulcerative Colitis (Severe UC) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Ulcerative Colitis (Ulcerative Proctitis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Ulcerative Colitis (Ulcerative Proctitis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Ulcerative Colitis (Proctosigmoiditis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Ulcerative Colitis (Proctosigmoiditis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Ulcerative Colitis (Left-sided Colitis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Ulcerative Colitis (Left-sided Colitis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Ulcerative Colitis (Pancolitis or Universal Colitis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Ulcerative Colitis (Pancolitis or Universal Colitis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Ulcerative Colitis (Fulminant Colitis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Ulcerative Colitis (Fulminant Colitis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Ulcerative Colitis (Small Molecules) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Ulcerative Colitis (Small Molecules) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Ulcerative Colitis (Biologics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Ulcerative Colitis (Biologics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Ulcerative Colitis (Anti-Inflammatory Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Ulcerative Colitis (Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Ulcerative Colitis (Anti-TNF Biologics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Ulcerative Colitis (Anti-TNF Biologics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Ulcerative Colitis (Immunosuppressant) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Ulcerative Colitis (Immunosuppressant) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Ulcerative Colitis (Calcineurin Inhibitors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Ulcerative Colitis (Calcineurin Inhibitors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Ulcerative Colitis (Other Drug Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Ulcerative Colitis (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Global: Ulcerative Colitis (Oral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Global: Ulcerative Colitis (Oral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Global: Ulcerative Colitis (Injectable) Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Global: Ulcerative Colitis (Injectable) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Global: Ulcerative Colitis (Hospital Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Global: Ulcerative Colitis (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Global: Ulcerative Colitis (Retail Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Global: Ulcerative Colitis (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Global: Ulcerative Colitis (Drug Store) Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Global: Ulcerative Colitis (Drug Store) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Global: Ulcerative Colitis (Other Distribution Channels) Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Global: Ulcerative Colitis (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: North America: Ulcerative Colitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: North America: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: United States: Ulcerative Colitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: United States: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Canada: Ulcerative Colitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Canada: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Asia-Pacific: Ulcerative Colitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Asia-Pacific: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: China: Ulcerative Colitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: China: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Japan: Ulcerative Colitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Japan: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: India: Ulcerative Colitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: India: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: South Korea: Ulcerative Colitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: South Korea: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Australia: Ulcerative Colitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Australia: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Indonesia: Ulcerative Colitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Indonesia: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Others: Ulcerative Colitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Others: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Europe: Ulcerative Colitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Europe: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Germany: Ulcerative Colitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Germany: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: France: Ulcerative Colitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: France: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: United Kingdom: Ulcerative Colitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: United Kingdom: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Italy: Ulcerative Colitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Italy: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Spain: Ulcerative Colitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Spain: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Russia: Ulcerative Colitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Russia: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Others: Ulcerative Colitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 90: Others: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 91: Latin America: Ulcerative Colitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 92: Latin America: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 93: Brazil: Ulcerative Colitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 94: Brazil: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 95: Mexico: Ulcerative Colitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 96: Mexico: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 97: Others: Ulcerative Colitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 98: Others: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 99: Middle East and Africa: Ulcerative Colitis Market: Sales Value (in Million US$), 2016 & 2021
Figure 100: Middle East and Africa: Ulcerative Colitis Market: Breakup by Country (in %), 2021
Figure 101: Middle East and Africa: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 102: Global: Ulcerative Colitis Industry: SWOT Analysis
Figure 103: Global: Ulcerative Colitis Industry: Value Chain Analysis
Figure 104: Global: Ulcerative Colitis Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Ulcerative Colitis Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Ulcerative Colitis Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Ulcerative Colitis Market Forecast: Breakup by Disease Type (in Million US$), 2022-2027
Table 4: Global: Ulcerative Colitis Market Forecast: Breakup by Molecule Type (in Million US$), 2022-2027
Table 5: Global: Ulcerative Colitis Market Forecast: Breakup by Drug Type (in Million US$), 2022-2027
Table 6: Global: Ulcerative Colitis Market Forecast: Breakup by Route of Administration (in Million US$), 2022-2027
Table 7: Global: Ulcerative Colitis Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 8: Global: Ulcerative Colitis Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 9: Global: Ulcerative Colitis Market: Competitive Structure
Table 10: Global: Ulcerative Colitis Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links